Novel Med Therapeutics Cleveland, OH - 44106

Novel Med Therapeutics is categorized under Drugs, Proprietaries, and Sundries in Cleveland, OH and active since 2003.

Novel Med Therapeutics was established in 2003, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 4242101 by the NAICS.

If you are seeking more information, feel free to contact Rekha Bansal, President at the company’s single location by writing to 11000 Cedar Avenue, Cleveland, Ohio OH 44106 or by phoning (216) 707-1776. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Novel Med Therapeutics
Contact Person: Rekha Bansal, President
Address: 11000 Cedar Avenue, Cleveland, Ohio 44106
Phone Number: (216) 707-1776
Website Address: novelmed.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drugs, Proprietaries, and Sundries
SIC Code: 5122
NAICS Code: 4242101
Share This Business:

Novel Med Therapeutics was started in 2003 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Rekha Bansal, President for inquiries that concern Novel Med Therapeutics by calling the company number (216) 707-1776, as your correspondence is most welcome. Additionally, the physical location of the single location of Novel Med Therapeutics can be found at the coordinates 41.49973,-81.6079 as well as the street address 11000 Cedar Avenue in Cleveland, Ohio 44106.

For its online presence, you may visit Novel Med Therapeutics’s website at novelmed.com and engage with its social media outlets through on Twitter and on Facebook.